1
|
Coimbra S, Reis F, Nunes S, Viana S, Rocha S, Valente M, Catarino C, Rocha-Pereira P, Bronze-Da-Rocha E, Oliveira J, Fernandes J, Madureira J, Faria M, Miranda V, Belo L, Santos-Silva A. Metabolic syndrome and cardiovascular disease risk in end-stage renal disease patients. Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.06.714] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
2
|
Coimbra S, Reis F, Nunes S, Viana S, Valente MJ, Rocha S, Catarino C, Rocha-Pereira P, Bronze-Da-Rocha E, Oliveira JG, Madureira J, Fernandes JC, Do Sameiro-Faria M, Miranda V, Belo L, Santos-Silva A. FP730EFFECTS OF STATINS THERAPY ON LDL SUBFRACTIONS AND INFLAMMATION, IN END-STAGE RENAL DISEASE PATIENTS ON DIALYSIS. Nephrol Dial Transplant 2019. [DOI: 10.1093/ndt/gfz106.fp730] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
| | - Flávio Reis
- CNC.IBILI Consortium & CIBB Consortium, Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal
| | - Sara Nunes
- CNC.IBILI Consortium & CIBB Consortium, Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal
| | - Sofia Viana
- CNC.IBILI Consortium & CIBB Consortium, Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Valente MJ, Rocha S, Coimbra S, Catarino C, Rocha-Pereira P, Bronze-Da-Rocha E, Oliveira JG, Madureira J, Fernandes JC, Do Sameiro-Faria M, Miranda V, Belo L, Santos-Silva A. FP725PENTRAXIN 3 IN END-STAGE RENAL DISEASE: MULTIPLE RISK BIOMARKER AND PREDICTOR OF ALL-CAUSE MORTALITY. Nephrol Dial Transplant 2019. [DOI: 10.1093/ndt/gfz106.fp725] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
4
|
Do Sameiro-Faria M, Rocha S, Ribeiro S, Coimbra S, Catarino C, Valente MJ, Rocha-Pereira P, Bronze-Da-Rocha E, Oliveira JG, Madureira J, Fernandes JC, Miranda V, Belo L, Santos-Silva A. SP674IN DIALYSIS PATIENTS FUROSEMIDE THERAPY IS FAVORABLY RELATED WITH INFLAMMATORY RESPONSE, FIBRINOLYSIS, AND BIOMARKERS OF RESIDUAL RENAL FUNCTION. Nephrol Dial Transplant 2019. [DOI: 10.1093/ndt/gfz103.sp674] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
5
|
Pedroso JP, Valente MJ, Rocha S, Coimbra S, Catarino C, Rocha-Pereira P, Bronze-Da-Rocha E, Carvalho M, Oliveira JG, Madureira J, Fernandes JC, Do Sameiro-Faria M, Miranda V, Belo L, Santos-Silva A. SP666MACHINE LEARNING IN PREDICTION OF VULNERABLE OR RESILIENT END-STAGE RENAL DISEASE PATIENTS. Nephrol Dial Transplant 2019. [DOI: 10.1093/ndt/gfz103.sp666] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
6
|
Catarino C, Rocha S, Valente MJ, Coimbra S, Rocha-Pereira P, Bronze-Da-Rocha E, Sá-Fernandes V, Santos-Martins M, Bettencourt N, Nunes JP, Beco A, Marques SM, Do Sameiro-Faria M, Miranda V, Belo L, Santos-Silva A. SP543ASSOCIATION OF PTX3, NT-proBNP AND LEFT VENTRICULAR HYPERTROPHY IN PATIENTS ON DIALYSIS. Nephrol Dial Transplant 2019. [DOI: 10.1093/ndt/gfz103.sp543] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
7
|
Rocha S, Nascimento H, Valente MJ, Coimbra S, Bronze-Da-Rocha E, Catarino C, Rocha-Pereira P, Oliveira JG, Madureira J, Fernandes JC, Do Sameiro-Faria M, Miranda V, Belo L, Santos-Silva A. SP637INFLAMMATION AND CELL-FREE DNA AS BIOMARKERS FOR THE OUTCOME OF END STAGE RENAL DISEASE PATIENTS. Nephrol Dial Transplant 2019. [DOI: 10.1093/ndt/gfz103.sp637] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
8
|
Santos-Martins M, Sameiro-Faria M, Ribeiro S, Rocha-Pereira P, Nascimento H, Reis F, Miranda V, Quintanilha A, Belo L, Beirão I, Santos-Silva A, Bronze-Da-Rocha E, Costa E. TLR4 and TLR9 Polymorphisms Effect on Inflammatory Response in End-Stage Renal Disease Patients. EUR J INFLAMM 2014. [DOI: 10.1177/1721727x1401200314] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
Toll-like receptors (TLRs) play a key role in the response of innate and adaptive immune system to microbial and endogenous ligands. Inflammation is a common feature in end-stage renal disease (ESRD) patients; however, the mechanisms/factors triggering the inflammatory process are still poorly clarified. Our aim was to analyze the impact of the c.-1486T>C and c.896A>G polymorphisms in TLR9 and TLR4 genes, respectively, on the inflammatory response of ESRD patients. Clinical and laboratory evaluation was carried out on 184 ESRD patients. Polymerase chain reaction followed by restriction fragmens length polymorphisms (PCR-RFLP) was employed for genotyping of TLR-4 c.896A>G and TLR-9 c.-1486T>C polymorphisms. The prevalence of AA and AG of TLR4 c.896A>G polymorphism in ESRD patients was 97.8% and 2.2%, respectively. None of the individuals showed a homozygous TLR4 polymorphism. Concerning the TLR9 c.-1486T>C polymorphism, we found that ESRD patients showed a prevalence of TC and CC genotypes of 57.1% and 20.6%, respectively. We found that the heterozygous patients for the TLR4 c.896A>G polymorphism presented an increased level in lymphocyte count, a decrease in neutrophil/lymphocyte ratio and in serum levels of hepcidin. Regarding the TLR9 c.-1486T>C polymorphism, we found that it is associated with decreased white blood cell and neutrophil counts, ferritin and CRP serum levels, and with an increase in serum levels of creatinine. Our data suggest that the presence of the studied polymorphisms is associated with a decreased inflammatory response in ESRD patients under hemodialysis, and, thus its presence might have beneficial effects in ESRD patients. Moreover, our data provide new insights in the role of TLR polymorphisms in renal disease, which might have impact in the near future for the development of innovative therapies.
Collapse
Affiliation(s)
- M. Santos-Martins
- Abel Solazar Institute of Biomedical Sciences, University of Porto, Porto, Portugal
| | - M. Sameiro-Faria
- Abel Solazar Institute of Biomedical Sciences, University of Porto, Porto, Portugal
- Nephrocare Portugal, SA-Nephrocare Maia, Maia, Portugal
| | - S. Ribeiro
- UCIBIO@REQUIMTE, Laboratory of Biochemistry, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal
| | - P. Rocha-Pereira
- Abel Solazar Institute of Biomedical Sciences, University of Porto, Porto, Portugal
- UCIBIO@REQUIMTE, Laboratory of Biochemistry, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal
- Health Sciences Research Center, University of Beira Interior, Covilhã, Portugal
| | - H. Nascimento
- UCIBIO@REQUIMTE, Laboratory of Biochemistry, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal
| | - F. Reis
- IBILI, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
| | - V. Miranda
- Nephrocare Portugal, SA-Nephrocare Maia, Maia, Portugal
| | - A. Quintanilha
- Abel Solazar Institute of Biomedical Sciences, University of Porto, Porto, Portugal
- Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal
| | - L. Belo
- UCIBIO@REQUIMTE, Laboratory of Biochemistry, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal
| | - I. Beirão
- Abel Solazar Institute of Biomedical Sciences, University of Porto, Porto, Portugal
- Nephrology Service, Hospital Centre of Porto, Porto, Portugal
- UMIB, Unit for Multidisciplinary Research in Biomedicine, ICBAS, University of Porto, Porto, Portugal
| | - A. Santos-Silva
- UCIBIO@REQUIMTE, Laboratory of Biochemistry, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal
- Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal
| | - E. Bronze-Da-Rocha
- UCIBIO@REQUIMTE, Laboratory of Biochemistry, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal
| | - E. Costa
- UCIBIO@REQUIMTE, Laboratory of Biochemistry, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal
| |
Collapse
|